CBS Gene Sulfur Metabolism and Inflammation | Decoding Inflammation

By Alberto Rivera, MD · 2026-06-25 · 5 min read

The Gatekeeper of Transsulfuration The CBS (cystathionine beta-synthase) gene serves as a critical junction in human biochemistry, acting as the primary gatekeeper of the transsulfuration pathway. This enzyme facilitates the irreversible conversion of homocysteine into cystathionine, utilizing vitamin B6 (pyridoxal-5-phosphate) as a necessary cofactor. When we examine the epigenetic landscape of chronic inflammation, the CBS enzyme emerges as a central player because it dictates the flow of sulfur-containing amino acids from the methylation cycle into the downstream production of antioxidants and waste products. ## Metabolic Consequences of CBS Up-regulation Most clinical attention focuses on CBS up-regulations, such as the C699T polymorphism. While a fast CBS enzyme lowers homocysteine levels—often viewed as a cardiovascular benefit—it can paradoxically increase the systemic inflammatory burden. An overactive transsulfuration pathway leads to the excessive production of ammonia and sulfites. Sulfites are highly reactive and pro-inflammatory; they can trigger mast cell degranulation and exacerbate neurological symptoms. If the Sulfite Oxidase (SUOX) enzyme cannot keep pace with this influx, the resulting sulfite accumulation depletes the body’s pool of molybdenum and significantly increases oxidative stress. This biochemical bottleneck is a frequently overlooked driver of chronic, low-grade inflammation. ## Glutathione and the Redox Balance Cysteine produced via the CBS pathway is the rate-limiting precursor for glutathione, the body master antioxidant. However, in the context of CBS dysregulation, the path to glutathione is not always efficient. The metabolic stress caused by ammonia and sulfite toxicity can consume antioxidant reserves faster than they are produced. This creates a state of systemic inflammation where the patient may have high markers of oxidative damage despite having the genetic machinery for glutathione synthesis. We see this often in patients with chemical sensitivities and chronic fatigue, where the sulfur metabolism is shifted toward toxicity rather than protection. ## Clinical Integration for Inflammatory Management For practitioners, decoding the CBS gene requires a nuanced approach. It is not enough to identify a variant; we must assess the functional output of the pathway through clinical markers such as urine sulfate measurements and plasma amino acid profiles. Managing the sulfur load through diet—temporarily reducing high-sulfur foods like cruciferous vegetables and animal proteins—and supporting enzymatic cofactors like molybdenum and manganese can significantly reduce the inflammatory burden. By stabilizing the transsulfuration pathway, we address a foundational pillar of epigenetic health and immune regulation, moving beyond symptom management toward true metabolic restoration.